- Home
- TXMD vs TLPH Comparison
TXMD vs TLPH Comparison
Compare TXMD & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TXMD
- TLPH
- Stock Information
- Founded
- TXMD 2008
- TLPH 2005
- Country
- TXMD United States
- TLPH United States
- Employees
- TXMD N/A
- TLPH N/A
- Industry
- TXMD Biotechnology: Pharmaceutical Preparations
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- TXMD Health Care
- TLPH Health Care
- Exchange
- TXMD Nasdaq
- TLPH Nasdaq
- Market Cap
- TXMD 12.8M
- TLPH 12.7M
- IPO Year
- TXMD N/A
- TLPH 2011
- Fundamental
- Price
- TXMD $1.06
- TLPH $0.67
- Analyst Decision
- TXMD
- TLPH Strong Buy
- Analyst Count
- TXMD 0
- TLPH 2
- Target Price
- TXMD N/A
- TLPH $4.50
- AVG Volume (30 Days)
- TXMD 852.1K
- TLPH 112.7K
- Earning Date
- TXMD 11-12-2024
- TLPH 03-05-2025
- Dividend Yield
- TXMD N/A
- TLPH N/A
- EPS Growth
- TXMD N/A
- TLPH N/A
- EPS
- TXMD N/A
- TLPH N/A
- Revenue
- TXMD $1,596,000.00
- TLPH $281,000.00
- Revenue This Year
- TXMD $605.07
- TLPH N/A
- Revenue Next Year
- TXMD $1.11
- TLPH N/A
- P/E Ratio
- TXMD N/A
- TLPH N/A
- Revenue Growth
- TXMD N/A
- TLPH N/A
- 52 Week Low
- TXMD $0.70
- TLPH $0.50
- 52 Week High
- TXMD $2.75
- TLPH $1.61
- Technical
- Relative Strength Index (RSI)
- TXMD 44.74
- TLPH 55.43
- Support Level
- TXMD $0.99
- TLPH $0.55
- Resistance Level
- TXMD $1.14
- TLPH $0.64
- Average True Range (ATR)
- TXMD 0.27
- TLPH 0.06
- MACD
- TXMD -0.00
- TLPH 0.01
- Stochastic Oscillator
- TXMD 20.69
- TLPH 94.06
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.